Lipid Keratopathy Management With Therapeutic Scleral Lens Wear.

John D Gelles, Kyla E Hillier, Sydney Krisa, Steven A Greenstein, Peter S Hersh
{"title":"Lipid Keratopathy Management With Therapeutic Scleral Lens Wear.","authors":"John D Gelles,&nbsp;Kyla E Hillier,&nbsp;Sydney Krisa,&nbsp;Steven A Greenstein,&nbsp;Peter S Hersh","doi":"10.1097/ICL.0000000000000866","DOIUrl":null,"url":null,"abstract":"<p><strong>Purpose: </strong>To report on the use of scleral lens therapy for a patient with lipid keratopathy secondary to rigid gas permeable contact lens wear and ocular surface disease.</p><p><strong>Methods: </strong>Case report and literature review.</p><p><strong>Results: </strong>A 40-year-old man with a history of keratoconus and rigid gas permeable contact lens wear, resulting in corneal neovascularization and lipid keratopathy. The patient reported to our clinic with central lipid keratopathy secondary to rigid gas permeable lens wear and ocular surface disease. Given the density, central location, and subsequent visual limitations induced by lipid deposition and topographical irregularity, penetrating keratoplasty and scleral contact lens wear were discussed as possible treatment options. In this case, scleral lens wear provided both visual improvement and resolution of lipid keratopathy. After 3 years, the patient has remained stable, with significant visual improvement and near-complete resolution of lipid keratopathy.</p><p><strong>Conclusions: </strong>This case illustrates the use of scleral lens wear in the therapeutic management of lipid keratopathy secondary to rigid gas permeable lens wear and ocular surface disease. For patients limited by lipid keratopathy and topographical irregularity, scleral lens wear may be used to achieve both visual and therapeutic outcomes.</p>","PeriodicalId":502139,"journal":{"name":"Eye & Contact Lens","volume":" ","pages":"91-94"},"PeriodicalIF":0.0000,"publicationDate":"2022-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"1","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Eye & Contact Lens","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1097/ICL.0000000000000866","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 1

Abstract

Purpose: To report on the use of scleral lens therapy for a patient with lipid keratopathy secondary to rigid gas permeable contact lens wear and ocular surface disease.

Methods: Case report and literature review.

Results: A 40-year-old man with a history of keratoconus and rigid gas permeable contact lens wear, resulting in corneal neovascularization and lipid keratopathy. The patient reported to our clinic with central lipid keratopathy secondary to rigid gas permeable lens wear and ocular surface disease. Given the density, central location, and subsequent visual limitations induced by lipid deposition and topographical irregularity, penetrating keratoplasty and scleral contact lens wear were discussed as possible treatment options. In this case, scleral lens wear provided both visual improvement and resolution of lipid keratopathy. After 3 years, the patient has remained stable, with significant visual improvement and near-complete resolution of lipid keratopathy.

Conclusions: This case illustrates the use of scleral lens wear in the therapeutic management of lipid keratopathy secondary to rigid gas permeable lens wear and ocular surface disease. For patients limited by lipid keratopathy and topographical irregularity, scleral lens wear may be used to achieve both visual and therapeutic outcomes.

治疗性巩膜晶状体佩戴对脂性角膜病变的治疗。
目的:报告一例硬透气隐形眼镜配戴和眼表疾病继发于脂质角膜病变的患者使用巩膜晶状体治疗。方法:病例报告和文献复习。结果:40岁男性,有圆锥角膜病史,佩戴硬性透气隐形眼镜,导致角膜新生血管形成和脂质性角膜病变。患者向我们诊所报告继发于硬性透气性晶状体磨损和眼表疾病的中枢性脂质性角膜病变。考虑到角膜的密度、中心位置以及随后由脂质沉积和地形不均匀引起的视力限制,我们讨论了穿透性角膜移植术和巩膜隐形眼镜佩戴作为可能的治疗选择。在这个病例中,巩膜晶状体的佩戴既能改善视力又能解决脂质性角膜病变。3年后,患者保持稳定,视力明显改善,脂质性角膜病变几乎完全消退。结论:本病例说明了巩膜晶状体配戴在硬透气晶状体配戴和眼表疾病继发于脂质性角膜病变的治疗管理中的应用。对于受脂质性角膜病变和地形不均匀限制的患者,可使用巩膜晶状体配戴来达到视力和治疗效果。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
自引率
0.00%
发文量
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信
小红书